A human monoclonal antibody blocking SARS-CoV-2 infection
Vaccines and targeted therapeutics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are currently lacking. Here, the authors report a human monoclonal antibody capable of neutralizing both authentic SARS-CoV and SARS-CoV-2 by targeting a common epitope.
Saved in:
Main Authors: | Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, Frank J. M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, Berend-Jan Bosch |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/d72494b81b034a06b5cf561dbf0e29c0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection
by: Chunyan Wang, et al.
Published: (2020) -
A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies
by: Chunyan Wang, et al.
Published: (2021) -
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
by: Roos M. de Jong, et al.
Published: (2021) -
Development and characterization of a monoclonal antibody blocking human TRPM4 channel
by: See Wee Low, et al.
Published: (2021) -
Nonhuman primate models for SARS.
by: Bart L Haagmans, et al.
Published: (2006)